Interventions for smoking cessation and reduction in individuals with schizophrenia.

@article{Tsoi2013InterventionsFS,
  title={Interventions for smoking cessation and reduction in individuals with schizophrenia.},
  author={Daniel T. Tsoi and Mamta Porwal and Angela C Webster},
  journal={The Cochrane database of systematic reviews},
  year={2013},
  volume={2},
  pages={
          CD007253
        }
}
BACKGROUND Individuals with schizophrenia smoke more heavily than the general population and this contributes to their higher morbidity and mortality from smoking-related illnesses. It remains unclear what interventions can help them to quit or to reduce smoking. OBJECTIVES To evaluate the benefits and harms of different treatments for nicotine dependence in schizophrenia. SEARCH METHODS We searched electronic databases including MEDLINE, EMBASE and PsycINFO from inception to October 2012… Expand

Paper Mentions

Interventional Clinical Trial
The study seeks to provide group tobacco cessation interventions among patients who use tobacco, and who attend Mathari National referral hospital on outpatient follow up. They will… Expand
ConditionsMental Illness
InterventionBehavioral
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review
TLDR
The findings support the efficacy and safety of first-line pharmacotherapies for the treatment of tobacco use disorder in smokers with schizophrenia and may warrant the consideration of the emerging use of electronic nicotine delivery systems while neuromodulation techniques also offer promise. Expand
Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review
TLDR
Evidence suggests that multimodal smoking cessation interventions for individuals diagnosed with schizophrenia should be recommended by clinicians, as they showed to be effective in reducing smoking without worsening psychiatric symptoms. Expand
Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review
TLDR
E-cigarettes could be considered as an applicable instrument for Tobacco Harm Reduction (THR) and smoking cessation and evidence suggests that they may effective as smoking cessation tool and may be less harmful alternatives to combustible cigarette smoking. Expand
Effective Cessation Strategies for Smokers with Schizophrenia.
TLDR
Converging evidence indicates that a majority of smokers with serious mental illness want to quit smoking and that available pharmacotherapeutic cessation aids combined with behavioral support are both effective for, and well tolerated by, these smokers. Expand
Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy
TLDR
Depressive symptoms declined in adults with schizophrenia during 12 weeks of varenicline treatment and cognitive behavioral therapy, independent of tobacco abstinence, in those who completed the trial. Expand
Smoking Cessation and Reduction in Schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial
TLDR
The goal is to propose an effective intervention to reduce the risk of tobacco smoking, as a complementary tool to treat tobacco addiction in schizophrenia, in schizophrenic smokers not intending to quit. Expand
Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.
TLDR
Varenicline appears to be significantly more effective than placebo in assisting with smoking cessation and reduction in people with severe mental illness and there is no clear evidence that varenic line was associated with an increased risk of neuropsychiatric or other adverse events compared with placebo. Expand
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.
TLDR
Tobacco cessation interventions were significantly associated with tobacco abstinence for two types of interventions, and offering tobacco cessation therapy to people in treatment or recovery for other drug dependence was not associated with a difference in abstinence rates from alcohol and other drugs. Expand
Effectiveness of smoking cessation programs for seriously mentally ill.
TLDR
It remains unclear whether people with severe mental illness could benefit from access to smoking cessation treatments, and it was seen that drug therapy and psychosocial interventions have indicated abstinence at 6 months for a few patients. Expand
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
TLDR
Among smokers with serious mental illness who attained initial abstinence with standard treatment, maintenance pharmacotherapy with varenicline and cognitive Behavioral therapy improved prolonged tobacco abstinence rates compared with cognitive behavioral therapy alone after 1 year of treatment and at 6 months after treatment discontinuation. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 143 REFERENCES
Smoking and Schizophrenia: Treatment Approaches within Primary Care
TLDR
Support for smoking cessation can be offered within primary health settings, and should include adequate and longer-term pharmacotherapies combined with psychosocial counseling, and numerous change attempts should be encouraged and normalized. Expand
Smoking cessation in severe mental illness: what works?
TLDR
Treating tobacco dependence in patients with stable psychiatric conditions does not worsen mental state and treatments that work in the general population work for those with severe mental illness and appear approximately equally effective. Expand
Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity
TLDR
These data suggest that affective flattening symptoms in smokers with schizophrenia may predict response to varenicline, a promising aid for smoking cessation in this population. Expand
A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.
TLDR
Findings demonstrate the utility of a nicotine replacement therapy plus motivational interviewing/cognitive behavior therapy smoking cessation intervention among individuals with a psychotic disorder. Expand
Nonmedication Smoking Reduction Program for Inpatients With Chronic Schizophrenia: A Randomized Control Design Study
TLDR
Behavioral group–oriented smoking reduction interventions can significantly reduce smoking behavior in hospitalized chronic clients with schizophrenia. Expand
A Comparison of Smoking Cessation Treatments for Persons with Schizophrenia and Other Serious Mental Illnesses
TLDR
Evidence of reduced smoking and importantly, no evidence of psychiatric exacerbation is found and most cessation studies exclude persons with serious mental illness. Expand
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
TLDR
The results of this proof-of-concept study indicate the efficacy and feasibility of this contingency management intervention for reducing smoking in individuals with schizophrenia. Expand
Smoking, quitting, and psychiatric disease: A review
TLDR
Despite the availability of effective smoking cessation pharmacotherapies and psychosocial interventions, as well as increasing evidence that individuals with psychiatric disorders are motivated to quit, nicotine dependence remains an undertreated and under-recognized problem within this patient population. Expand
Characteristics of smokers with a psychotic disorder and implications for smoking interventions
TLDR
Higher levels of nicotine dependence and concurrent hazardous use of alcohol or cannabis were associated with a younger age at smoking initiation, and the present sample was more likely to report stress reduction, stimulation and addiction as reasons for smoking, compared to a general sample of smokers. Expand
Predictors of early abstinence in smokers with schizophrenia.
TLDR
Later initiation of smoking was associated with increased and baseline attentional impairment with reduced odds of abstinence, and additional research to further the understanding of the relationship between Attentional impairment and cigarette smoking in schizophrenia may lead to improved nicotine dependence treatments for this group. Expand
...
1
2
3
4
5
...